BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9175750)

  • 1. 6-sulfooxymethylbenzo[a]pyrene is an ultimate electrophilic and carcinogenic form of the intermediary metabolite 6-hydroxymethylbenzo[a]pyrene.
    Flesher JW; Horn J; Lehner AF
    Biochem Biophys Res Commun; 1997 May; 234(3):554-8. PubMed ID: 9175750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The strong hepatocarcinogenicity of the electrophilic and mutagenic metabolite 6-sulfooxymethylbenzo[a]pyrene and its formation of benzylic DNA adducts in the livers of infant male B6C3F1 mice.
    Surh YJ; Liem A; Miller EC; Miller JA
    Biochem Biophys Res Commun; 1990 Oct; 172(1):85-91. PubMed ID: 2222484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro.
    Surh YJ; Liem A; Miller EC; Miller JA
    Carcinogenesis; 1989 Aug; 10(8):1519-28. PubMed ID: 2752526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenicity of 1-hydroxy-3-methylcholanthrene and its electrophilic sulfate ester 1-sulfooxy-3-methylcholanthrene in Sprague-Dawley rats.
    Flesher JW; Horn J; Lehner AF
    Biochem Biophys Res Commun; 1998 Feb; 243(1):30-5. PubMed ID: 9473474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-Sulfooxymethyl-12-methylbenz[a]anthracene is an exceptionally reactive electrophilic mutagen and ultimate carcinogen.
    Flesher JW; Horn J; Lehner AF
    Biochem Biophys Res Commun; 1997 Feb; 231(1):144-8. PubMed ID: 9070237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of hemin on mutagenicity of the electrophilic sulfuric acid ester of 6-hydroxymethylbenzo[a]pyrene.
    Hong ST; Cho YS; Surh YJ; Chung AS
    Chem Biol Interact; 1998 Feb; 109(1-3):255-65. PubMed ID: 9566750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive effect of chlorophyllin on mutagenicity and cytotoxicity of 6-sulfooxymethylbenzo[a]pyrene.
    Cho YS; Kim BY; Lee ST; Surh YJ; Chung AS
    Cancer Lett; 1996 Oct; 107(2):223-8. PubMed ID: 8947517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Sulfooxymethylbenz[a]anthracene is an ultimate electrophilic and carcinogenic form of 7-hydroxymethylbenz[a]anthracene.
    Flesher JW; Horn J; Lehner AF
    Biochem Biophys Res Commun; 1997 Feb; 231(3):712-6. PubMed ID: 9070878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine substitution as a probe for the role of the 6-position of benzo[a]pyrene in carcinogenesis.
    Buening MK; Levin W; Wood AW; Chang RL; Agranat I; Rabinovitz M; Buhler DR; Mah HD; Hernandez O; Simpson RB; Jerina DM; Conney AH; Miller EC; Miller JA
    J Natl Cancer Inst; 1983 Aug; 71(2):309-15. PubMed ID: 6308321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of vitamin C on the mutagenicity and covalent DNA binding of the electrophilic and carcinogenic metabolite, 6-sulfooxymethylbenzo[a]pyrene.
    Surh YJ; Park KK; Miller JA
    Carcinogenesis; 1994 May; 15(5):917-20. PubMed ID: 8200095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of 6-sulfooxymethylbenzo[a]pyrene in Salmonella typhimurium and Chinese hamster V79 cells.
    Cho YS; Kim KB; Chung AS
    Mutat Res; 1998 Feb; 397(2):263-9. PubMed ID: 9541651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenicity and metabolic profiles of 6-substituted benzo[a]pyrene derivatives on mouse skin.
    Cavalieri E; Roth R; Grandjean C; Althoff J; Patil K; Liakus S; Marsh S
    Chem Biol Interact; 1978 Jul; 22(1):53-67. PubMed ID: 688525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of 6-hydroxymethylbenzo(a)pyrene as a proximate carcinogen of benzo(a(pyrene and 6-methylbenzo(a)pyrene.
    Flesher JW; Sydnor KL
    Int J Cancer; 1973 Mar; 11(2):433-7. PubMed ID: 4790701
    [No Abstract]   [Full Text] [Related]  

  • 14. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic activity of benzo[a]pyrene and some of its synthetic derivatives by direct injection into the mouse fetus.
    Rossi L; Barbieri O; Sanguineti M; Staccione A; Santi LF; Santi L
    Carcinogenesis; 1983; 4(2):153-6. PubMed ID: 6297822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenicity and polarographic behaviour of dibenzo[a,h]pyrene, 4,11-diazadibenzo[a,h]pyrene and 7,14-diazadibenzo[a,h]pyrene.
    Bahna L; Podaný V; Benesová M; Godál A; Dufour M; Jacquignon P; Vachálková A
    Neoplasma; 1979; 26(1):23-8. PubMed ID: 431753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clastogenic and carcinogenic effects of intravenous beta-propiolactone and benzo(a)pyrene in rats.
    Rees ED; Shuck AE; Lowry JQ; Smith TM; Lipscomb H
    J Environ Pathol Toxicol; 1979; 2(6):1475-85. PubMed ID: 528852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemically induced sarcomas in Sprague-Dawley rats: dose effects on autoantibody levels and tumor progression.
    Faiderbe S; Chagnaud JL; Geffard M
    Cancer Detect Prev; 1995; 19(3):274-7. PubMed ID: 7750116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.